Insmed, Inc. (INSM)
126.53
-0.15
(-0.12%)
USD |
NASDAQ |
Sep 04, 10:55
Insmed Cash and Short Term Investments (Annual) : 1.430B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.430B |
| December 31, 2024 | 1.434B |
| December 31, 2023 | 780.45M |
| December 31, 2022 | 1.148B |
| December 31, 2021 | 716.78M |
| December 31, 2020 | 532.76M |
| December 31, 2019 | 487.43M |
| December 31, 2018 | 495.07M |
| December 31, 2017 | 381.16M |
| December 31, 2016 | 162.59M |
| December 31, 2015 | 282.88M |
| December 31, 2014 | 159.23M |
| December 31, 2013 | 113.89M |
| December 31, 2012 | 92.94M |
| Date | Value |
|---|---|
| December 31, 2011 | 76.27M |
| December 31, 2010 | 108.05M |
| December 31, 2009 | 122.18M |
| December 31, 2008 | 2.397M |
| December 31, 2007 | 16.48M |
| December 31, 2006 | 24.52M |
| December 31, 2005 | 19.12M |
| December 31, 2004 | 9.507M |
| December 31, 2003 | 29.53M |
| December 31, 2002 | 27.34M |
| December 31, 2001 | 51.25M |
| December 31, 2000 | 83.08M |
| December 31, 1999 | 38.48M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Biogen, Inc. | 3.816B |
| Gilead Sciences, Inc. | 9.613B |
| Agios Pharmaceuticals, Inc. | 854.42M |